The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chong, M. M. W.
Right arrow Articles by Thomas, H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chong, M. M. W.
Right arrow Articles by Thomas, H. E.
The Journal of Immunology, 2004, 172: 5714-5721.
Copyright © 2004 by The American Association of Immunologists

Suppressor of Cytokine Signaling-1 Overexpression Protects Pancreatic {beta} Cells from CD8+ T Cell-Mediated Autoimmune Destruction1

Mark M. W. Chong*,{dagger}, Ye Chen{dagger}, Rima Darwiche*, Nadine L. Dudek*, Windy Irawaty{dagger}, Pere Santamaria{ddagger}, Janette Allison§, Thomas W. H. Kay2,* and Helen E. Thomas*

* St. Vincent’s Institute of Medical Research, Fitzroy, Victoria, Australia; {dagger} Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia; {ddagger} Department of Microbiology and Infectious Diseases and Julia McFarlane Diabetes Research Center, University of Calgary, Alberta, Canada; and § Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia

In type 1 diabetes, cytokine action on {beta} cells potentially contributes to {beta} cell destruction by direct cytotoxicity, inducing Fas expression, and up-regulating class I MHC and chemokine expression to increase immune recognition. To simultaneously block {beta} cell responsiveness to multiple cytokines, we overexpressed suppressor of cytokine signaling-1 (SOCS-1). This completely prevented progression to diabetes in CD8+ TCR transgenic nonobese diabetic (NOD) 8.3 mice without affecting pancreas infiltration and partially prevented diabetes in nontransgenic NOD mice. SOCS-1 appeared to protect at least in part by inhibiting TNF- and IFN-{gamma}-induced Fas expression on {beta} cells. Fas expression was up-regulated on {beta} cells in vivo in prediabetic NOD8.3 mice, and this was inhibited by SOCS-1. Additionally, IFN-{gamma}-induced class I MHC up-regulation and TNF- and IFN-{gamma}-induced IL-15 expression by {beta} cells were inhibited by SOCS-1, which correlated with suppressed 8.3 T cell proliferation in vitro. Despite this, 8.3 T cell priming in vivo appeared unaffected. Therefore, blocking {beta} cell responses to cytokines impairs recognition by CD8+ T cells and blocks multiple mechanisms of {beta} cell destruction, but does not prevent T cell priming and recruitment to the islets. Our findings suggest that increasing SOCS-1 expression may be useful as a strategy to block CD8+ T cell-mediated type 1 diabetes as well as to more generally prevent cytokine-dependent tissue destruction in inflammatory diseases.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
X. Huang, D. J. Moore, R. J. Ketchum, C. S. Nunemaker, B. Kovatchev, A. L. McCall, and K. L. Brayman
Resolving the Conundrum of Islet Transplantation by Linking Metabolic Dysregulation, Inflammation, and Immune Regulation
Endocr. Rev., August 1, 2008; 29(5): 603 - 630.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. G. Ronn, N. Billestrup, and T. Mandrup-Poulsen
Diabetes and Suppressors of Cytokine Signaling Proteins
Diabetes, February 1, 2007; 56(2): 541 - 548.
[Full Text] [PDF]


Home page
DiabetesHome page
N. L. Dudek, H. E. Thomas, L. Mariana, R. M. Sutherland, J. Allison, E. Estella, E. Angstetra, J. A. Trapani, P. Santamaria, A. M. Lew, et al.
Cytotoxic T-Cells From T-Cell Receptor Transgenic NOD8.3 Mice Destroy {beta}-Cells via the Perforin and Fas Pathways
Diabetes, September 1, 2006; 55(9): 2412 - 2418.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. D McKenzie, N. L Dudek, L. Mariana, M. M. Chong, J. A Trapani, T. W. Kay, and H. E Thomas
Perforin and Fas induced by IFN{gamma} and TNF{alpha} mediate beta cell death by OT-I CTL
Int. Immunol., June 1, 2006; 18(6): 837 - 846.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.